The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nicardipine Hydrochloride Injection Market Research Report 2024
Synopsis
Nicardipine hydrochloride injection is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible.
The global Nicardipine Hydrochloride Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nicardipine Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nicardipine Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nicardipine Hydrochloride Injection include Baxter, Hikma, Mylan, Sun Pharma, Chiesi, Wockhardt, DMS Pharmaceutical, Sandoz and Navinta, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nicardipine Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicardipine Hydrochloride Injection.
Report Scope
The Nicardipine Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicardipine Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicardipine Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Hikma
Mylan
Sun Pharma
Chiesi
Wockhardt
DMS Pharmaceutical
Sandoz
Navinta
Teva
Shanghai Furen Medicine
Segment by Type
20 mg / 200 mL
40 mg / 200 mL
Segment by Application
Hospital
Clinic
Recovery Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nicardipine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nicardipine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nicardipine hydrochloride injection is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible.
The global Nicardipine Hydrochloride Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nicardipine Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nicardipine Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nicardipine Hydrochloride Injection include Baxter, Hikma, Mylan, Sun Pharma, Chiesi, Wockhardt, DMS Pharmaceutical, Sandoz and Navinta, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nicardipine Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicardipine Hydrochloride Injection.
Report Scope
The Nicardipine Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicardipine Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicardipine Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Hikma
Mylan
Sun Pharma
Chiesi
Wockhardt
DMS Pharmaceutical
Sandoz
Navinta
Teva
Shanghai Furen Medicine
Segment by Type
20 mg / 200 mL
40 mg / 200 mL
Segment by Application
Hospital
Clinic
Recovery Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nicardipine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nicardipine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nicardipine Hydrochloride Injection Market Overview
1.1 Product Overview and Scope of Nicardipine Hydrochloride Injection
1.2 Nicardipine Hydrochloride Injection Segment by Type
1.2.1 Global Nicardipine Hydrochloride Injection Market Value Comparison by Type (2024-2030)
1.2.2 20 mg / 200 mL
1.2.3 40 mg / 200 mL
1.3 Nicardipine Hydrochloride Injection Segment by Application
1.3.1 Global Nicardipine Hydrochloride Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Recovery Center
1.4 Global Nicardipine Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Nicardipine Hydrochloride Injection Revenue 2019-2030
1.4.2 Global Nicardipine Hydrochloride Injection Sales 2019-2030
1.4.3 Global Nicardipine Hydrochloride Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nicardipine Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Nicardipine Hydrochloride Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nicardipine Hydrochloride Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nicardipine Hydrochloride Injection Average Price by Manufacturers (2019-2024)
2.4 Global Nicardipine Hydrochloride Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nicardipine Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicardipine Hydrochloride Injection, Product Type & Application
2.7 Nicardipine Hydrochloride Injection Market Competitive Situation and Trends
2.7.1 Nicardipine Hydrochloride Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nicardipine Hydrochloride Injection Players Market Share by Revenue
2.7.3 Global Nicardipine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nicardipine Hydrochloride Injection Retrospective Market Scenario by Region
3.1 Global Nicardipine Hydrochloride Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nicardipine Hydrochloride Injection Global Nicardipine Hydrochloride Injection Sales by Region: 2019-2030
3.2.1 Global Nicardipine Hydrochloride Injection Sales by Region: 2019-2024
3.2.2 Global Nicardipine Hydrochloride Injection Sales by Region: 2025-2030
3.3 Global Nicardipine Hydrochloride Injection Global Nicardipine Hydrochloride Injection Revenue by Region: 2019-2030
3.3.1 Global Nicardipine Hydrochloride Injection Revenue by Region: 2019-2024
3.3.2 Global Nicardipine Hydrochloride Injection Revenue by Region: 2025-2030
3.4 North America Nicardipine Hydrochloride Injection Market Facts & Figures by Country
3.4.1 North America Nicardipine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nicardipine Hydrochloride Injection Sales by Country (2019-2030)
3.4.3 North America Nicardipine Hydrochloride Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nicardipine Hydrochloride Injection Market Facts & Figures by Country
3.5.1 Europe Nicardipine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nicardipine Hydrochloride Injection Sales by Country (2019-2030)
3.5.3 Europe Nicardipine Hydrochloride Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicardipine Hydrochloride Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Nicardipine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nicardipine Hydrochloride Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Nicardipine Hydrochloride Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nicardipine Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Latin America Nicardipine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nicardipine Hydrochloride Injection Sales by Country (2019-2030)
3.7.3 Latin America Nicardipine Hydrochloride Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nicardipine Hydrochloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicardipine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nicardipine Hydrochloride Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicardipine Hydrochloride Injection Sales by Type (2019-2030)
4.1.1 Global Nicardipine Hydrochloride Injection Sales by Type (2019-2024)
4.1.2 Global Nicardipine Hydrochloride Injection Sales by Type (2025-2030)
4.1.3 Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2019-2030)
4.2 Global Nicardipine Hydrochloride Injection Revenue by Type (2019-2030)
4.2.1 Global Nicardipine Hydrochloride Injection Revenue by Type (2019-2024)
4.2.2 Global Nicardipine Hydrochloride Injection Revenue by Type (2025-2030)
4.2.3 Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
4.3 Global Nicardipine Hydrochloride Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nicardipine Hydrochloride Injection Sales by Application (2019-2030)
5.1.1 Global Nicardipine Hydrochloride Injection Sales by Application (2019-2024)
5.1.2 Global Nicardipine Hydrochloride Injection Sales by Application (2025-2030)
5.1.3 Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2019-2030)
5.2 Global Nicardipine Hydrochloride Injection Revenue by Application (2019-2030)
5.2.1 Global Nicardipine Hydrochloride Injection Revenue by Application (2019-2024)
5.2.2 Global Nicardipine Hydrochloride Injection Revenue by Application (2025-2030)
5.2.3 Global Nicardipine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
5.3 Global Nicardipine Hydrochloride Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Nicardipine Hydrochloride Injection Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Hikma
6.2.1 Hikma Corporation Information
6.2.2 Hikma Description and Business Overview
6.2.3 Hikma Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hikma Nicardipine Hydrochloride Injection Product Portfolio
6.2.5 Hikma Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Nicardipine Hydrochloride Injection Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Corporation Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharma Nicardipine Hydrochloride Injection Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates
6.5 Chiesi
6.5.1 Chiesi Corporation Information
6.5.2 Chiesi Description and Business Overview
6.5.3 Chiesi Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chiesi Nicardipine Hydrochloride Injection Product Portfolio
6.5.5 Chiesi Recent Developments/Updates
6.6 Wockhardt
6.6.1 Wockhardt Corporation Information
6.6.2 Wockhardt Description and Business Overview
6.6.3 Wockhardt Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wockhardt Nicardipine Hydrochloride Injection Product Portfolio
6.6.5 Wockhardt Recent Developments/Updates
6.7 DMS Pharmaceutical
6.6.1 DMS Pharmaceutical Corporation Information
6.6.2 DMS Pharmaceutical Description and Business Overview
6.6.3 DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DMS Pharmaceutical Nicardipine Hydrochloride Injection Product Portfolio
6.7.5 DMS Pharmaceutical Recent Developments/Updates
6.8 Sandoz
6.8.1 Sandoz Corporation Information
6.8.2 Sandoz Description and Business Overview
6.8.3 Sandoz Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sandoz Nicardipine Hydrochloride Injection Product Portfolio
6.8.5 Sandoz Recent Developments/Updates
6.9 Navinta
6.9.1 Navinta Corporation Information
6.9.2 Navinta Description and Business Overview
6.9.3 Navinta Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Navinta Nicardipine Hydrochloride Injection Product Portfolio
6.9.5 Navinta Recent Developments/Updates
6.10 Teva
6.10.1 Teva Corporation Information
6.10.2 Teva Description and Business Overview
6.10.3 Teva Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teva Nicardipine Hydrochloride Injection Product Portfolio
6.10.5 Teva Recent Developments/Updates
6.11 Shanghai Furen Medicine
6.11.1 Shanghai Furen Medicine Corporation Information
6.11.2 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Description and Business Overview
6.11.3 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Product Portfolio
6.11.5 Shanghai Furen Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicardipine Hydrochloride Injection Industry Chain Analysis
7.2 Nicardipine Hydrochloride Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicardipine Hydrochloride Injection Production Mode & Process
7.4 Nicardipine Hydrochloride Injection Sales and Marketing
7.4.1 Nicardipine Hydrochloride Injection Sales Channels
7.4.2 Nicardipine Hydrochloride Injection Distributors
7.5 Nicardipine Hydrochloride Injection Customers
8 Nicardipine Hydrochloride Injection Market Dynamics
8.1 Nicardipine Hydrochloride Injection Industry Trends
8.2 Nicardipine Hydrochloride Injection Market Drivers
8.3 Nicardipine Hydrochloride Injection Market Challenges
8.4 Nicardipine Hydrochloride Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Nicardipine Hydrochloride Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Nicardipine Hydrochloride Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Nicardipine Hydrochloride Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Nicardipine Hydrochloride Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Nicardipine Hydrochloride Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Nicardipine Hydrochloride Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Nicardipine Hydrochloride Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Nicardipine Hydrochloride Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Nicardipine Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nicardipine Hydrochloride Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nicardipine Hydrochloride Injection, Product Type & Application
Table 12. Global Key Manufacturers of Nicardipine Hydrochloride Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nicardipine Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicardipine Hydrochloride Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nicardipine Hydrochloride Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Nicardipine Hydrochloride Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Nicardipine Hydrochloride Injection Sales Market Share by Region (2019-2024)
Table 19. Global Nicardipine Hydrochloride Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Nicardipine Hydrochloride Injection Sales Market Share by Region (2025-2030)
Table 21. Global Nicardipine Hydrochloride Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Nicardipine Hydrochloride Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Nicardipine Hydrochloride Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Nicardipine Hydrochloride Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Nicardipine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Nicardipine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Nicardipine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Nicardipine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Nicardipine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Nicardipine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Nicardipine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Nicardipine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Nicardipine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Nicardipine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Nicardipine Hydrochloride Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Nicardipine Hydrochloride Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Nicardipine Hydrochloride Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Nicardipine Hydrochloride Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Nicardipine Hydrochloride Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nicardipine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Nicardipine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Nicardipine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Nicardipine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Nicardipine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Nicardipine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Nicardipine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Nicardipine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Nicardipine Hydrochloride Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Nicardipine Hydrochloride Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2019-2024)
Table 53. Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2025-2030)
Table 54. Global Nicardipine Hydrochloride Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Nicardipine Hydrochloride Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Nicardipine Hydrochloride Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Nicardipine Hydrochloride Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Nicardipine Hydrochloride Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Nicardipine Hydrochloride Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2019-2024)
Table 63. Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2025-2030)
Table 64. Global Nicardipine Hydrochloride Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Nicardipine Hydrochloride Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Nicardipine Hydrochloride Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Nicardipine Hydrochloride Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Nicardipine Hydrochloride Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Nicardipine Hydrochloride Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Baxter Corporation Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Baxter Nicardipine Hydrochloride Injection Product
Table 74. Baxter Recent Developments/Updates
Table 75. Hikma Corporation Information
Table 76. Hikma Description and Business Overview
Table 77. Hikma Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Hikma Nicardipine Hydrochloride Injection Product
Table 79. Hikma Recent Developments/Updates
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Mylan Nicardipine Hydrochloride Injection Product
Table 84. Mylan Recent Developments/Updates
Table 85. Sun Pharma Corporation Information
Table 86. Sun Pharma Description and Business Overview
Table 87. Sun Pharma Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sun Pharma Nicardipine Hydrochloride Injection Product
Table 89. Sun Pharma Recent Developments/Updates
Table 90. Chiesi Corporation Information
Table 91. Chiesi Description and Business Overview
Table 92. Chiesi Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Chiesi Nicardipine Hydrochloride Injection Product
Table 94. Chiesi Recent Developments/Updates
Table 95. Wockhardt Corporation Information
Table 96. Wockhardt Description and Business Overview
Table 97. Wockhardt Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Wockhardt Nicardipine Hydrochloride Injection Product
Table 99. Wockhardt Recent Developments/Updates
Table 100. DMS Pharmaceutical Corporation Information
Table 101. DMS Pharmaceutical Description and Business Overview
Table 102. DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. DMS Pharmaceutical Nicardipine Hydrochloride Injection Product
Table 104. DMS Pharmaceutical Recent Developments/Updates
Table 105. Sandoz Corporation Information
Table 106. Sandoz Description and Business Overview
Table 107. Sandoz Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sandoz Nicardipine Hydrochloride Injection Product
Table 109. Sandoz Recent Developments/Updates
Table 110. Navinta Corporation Information
Table 111. Navinta Description and Business Overview
Table 112. Navinta Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Navinta Nicardipine Hydrochloride Injection Product
Table 114. Navinta Recent Developments/Updates
Table 115. Teva Corporation Information
Table 116. Teva Description and Business Overview
Table 117. Teva Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Teva Nicardipine Hydrochloride Injection Product
Table 119. Teva Recent Developments/Updates
Table 120. Shanghai Furen Medicine Corporation Information
Table 121. Shanghai Furen Medicine Description and Business Overview
Table 122. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Product
Table 124. Shanghai Furen Medicine Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Nicardipine Hydrochloride Injection Distributors List
Table 128. Nicardipine Hydrochloride Injection Customers List
Table 129. Nicardipine Hydrochloride Injection Market Trends
Table 130. Nicardipine Hydrochloride Injection Market Drivers
Table 131. Nicardipine Hydrochloride Injection Market Challenges
Table 132. Nicardipine Hydrochloride Injection Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nicardipine Hydrochloride Injection
Figure 2. Global Nicardipine Hydrochloride Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Nicardipine Hydrochloride Injection Market Share by Type in 2023 & 2030
Figure 4. 20 mg / 200 mL Product Picture
Figure 5. 40 mg / 200 mL Product Picture
Figure 6. Global Nicardipine Hydrochloride Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Nicardipine Hydrochloride Injection Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Recovery Center
Figure 11. Global Nicardipine Hydrochloride Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Nicardipine Hydrochloride Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Nicardipine Hydrochloride Injection Sales (2019-2030) & (K Units)
Figure 14. Global Nicardipine Hydrochloride Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Nicardipine Hydrochloride Injection Report Years Considered
Figure 16. Nicardipine Hydrochloride Injection Sales Share by Manufacturers in 2023
Figure 17. Global Nicardipine Hydrochloride Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Nicardipine Hydrochloride Injection Players: Market Share by Revenue in 2023
Figure 19. Nicardipine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Nicardipine Hydrochloride Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Nicardipine Hydrochloride Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Nicardipine Hydrochloride Injection Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Nicardipine Hydrochloride Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Nicardipine Hydrochloride Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Nicardipine Hydrochloride Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Nicardipine Hydrochloride Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Nicardipine Hydrochloride Injection Sales Market Share by Country (2019-2030)
Figure 45. Latin America Nicardipine Hydrochloride Injection Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Nicardipine Hydrochloride Injection Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Nicardipine Hydrochloride Injection Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Nicardipine Hydrochloride Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Nicardipine Hydrochloride Injection by Type (2019-2030)
Figure 55. Global Revenue Market Share of Nicardipine Hydrochloride Injection by Type (2019-2030)
Figure 56. Global Nicardipine Hydrochloride Injection Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Nicardipine Hydrochloride Injection by Application (2019-2030)
Figure 58. Global Revenue Market Share of Nicardipine Hydrochloride Injection by Application (2019-2030)
Figure 59. Global Nicardipine Hydrochloride Injection Price (US$/Unit) by Application (2019-2030)
Figure 60. Nicardipine Hydrochloride Injection Value Chain
Figure 61. Nicardipine Hydrochloride Injection Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
